Connect with us


Toronto residents 80+ can start booking COVID-19 vaccination appointments online today – CTV Toronto



Torontonians aged 80 and older are now able to book a COVID-19 vaccination appointment at a city-run mass immunization clinic.

As of Friday afternoon, approximately 133,000 appointments were up for grabs for Toronto residents born in 1941 or earlier on the city’s website.

Appointments begin on Mar. 17 through to Apr. 11 at three mass immunization clinics across the city: The Metro Toronto Convention Center, Scarborough Town Centre and the Toronto Congress Centre.

Today the city also announced that three more city-run sites will be opening in the coming weeks.

Two will open on Mar. 29 at Malvern Community Recreation Centre and Mitchell Field Community Centre, while the third will open at The Hangar on Apr. 5.

The city says three more clinics are preparing to open and are waiting for more vaccine supply. The expected opening dates for these clinics is unknown.

READ MORE: Ontario releases list of pharmacies where COVID-19 vaccine will be available

Tory said the city’s booking portal has been tested to run efficiently but bumps along the road could still occur.

Once residents complete their booking online, users will get a confirmation number and a QR code for their appointments.

People who arrive at one of the open mass immunization clinics without a confirmed appointment will not be vaccinated.

Mayor John Tory spoke to CP24 this morning and said the city’s booking portal has been tested to run efficiently but bumps along the road could still occur.

“For example, in the early going when you open something like this which will happen later this morning there’s a big rush to go on there and you have to make sure that that kind of loading doesn’t cause undue problems,” he said.

“But look, I have to be an optimist about this. I think the thing has been tested, it’s been well put together and hopefully it will work well for people, that’s the idea.”

The city is asking people who are not yet eligible for a vaccine to not visit the booking platform to avoid slowing it down.

Toronto’s registration site kicks off three days ahead of Monday’s launch date for a provincewide portal to book vaccination appointments.

The city will start using that system on Monday but residents will still be able to access the booking platform by visiting the city’s website.

Toronto’s booking portal will not be available from 8 p.m. on Sunday to Monday morning as the city transfers its registration site to the province’s system.

In addition, as of Monday people will be able to book appointments by phone and a call centre will also open up for extra support.

Meanwhile, approximately 25 smaller vaccination clinics will continue to operate today at a number of hospitals and community health-care centres in Toronto for priority groups. Eligible people include seniors living in congregate settings, health-care workers, Indigenous adults and residents aged 80 and older.

Let’s block ads! (Why?)

Source link

Continue Reading


What supply chain shortages look like for two Canadians –



[unable to retrieve full-text content]

  1. What supply chain shortages look like for two Canadians
  2. Canadian ski resorts struggle to hire enough workers ahead of season
  3. Calls to end ‘hybrid’ classrooms in Ontario with in-person and virtual teaching
  4. A life story told in outfits: Anahid Chujunian discovers her voice one thrift find at a time
  5. Amateur astronomer in Dartmouth has an asteroid named after him
  6. View Full coverage on Google News

Source link

Continue Reading


FDA says kid-sized Pfizer vaccine doses appear highly effective, safe –



U.S. health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the country weighs beginning vaccinations in youngsters.

The Food and Drug Administration posted its analysis of Pfizer’s data ahead of a public meeting next week to debate whether the shots are ready for the nation’s roughly 28 million children ages 5 to 11. The agency will ask a panel of outside vaccine experts to vote on that question.

In their analysis, FDA scientists concluded that in almost every scenario the vaccine’s benefit for preventing hospitalizations and death from COVID-19 would outweigh any serious potential side effects in children. But agency reviewers stopped short of calling for Pfizer’s shot to be authorized.

The agency will put that question to its panel of independent advisers next Tuesday and weigh their advice before making its own decision.

U.S. children could begin vaccinations next month

If the FDA authorizes the shots, the Centers for Disease Control and Prevention will make additional recommendations on who should receive them the first week of November. Children could begin vaccinations early next month — with the first youngsters in line fully protected by Christmas.

Full-strength Pfizer shots already are recommended for anyone 12 or older, but pediatricians and many parents are anxiously awaiting protection for younger children to stem infections from the extra-contagious delta variant and help keep kids in school.

WATCH | Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11:

Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

13 hours ago

Pfizer publicly released data from its coronavirus vaccine trial appearing to show that it’s both safe and effective for children aged five to 11. But that data is now being reviewed by regulators, and parents want to carefully weigh the risks. 2:03

The FDA review affirmed results from Pfizer posted earlier in the day showing the two-dose shot was nearly 91 per cent effective at preventing symptomatic infection in young children. Researchers calculated the figure based on 16 COVID-19 cases in youngsters given dummy shots versus three cases among vaccinated children. There were no severe illnesses reported among any of the youngsters, but the vaccinated ones had much milder symptoms than their unvaccinated counterparts.

Most of the study data was collected in the U.S. during August and September, when the delta variant had become the dominant COVID-19 strain.

No new side effects

The FDA review found no new or unexpected side effects, which mostly consisted of sore arms, fever or achiness that teens experience.

However, FDA scientists noted that the study wasn’t large enough to detect extremely rare side effects, including myocarditis, a type of heart inflammation that occasionally occurs after the second dose.

The agency used statistical modelling to try to predict how many hospitalizations and deaths from COVID-19 the vaccine would prevent versus the number of potential heart side effects it might cause. In four scenarios of the pandemic, the vaccine clearly prevented more hospitalizations than would be expected from the heart side effect. Only when virus cases were extremely low would the vaccine cause more hospitalizations than it would prevent. But overall, regulators concluded that the vaccine’s protective benefits “would clearly outweigh” its risks.

While children run a lower risk of severe illness or death than older people, COVID-19 has killed more than 630 Americans 18 and under, according to the CDC. Nearly 6.2 million children have been infected with the coronavirus, more than 1.1 million in the last six weeks as the delta variant surged, the American Academy of Pediatrics says.

The Biden administration has purchased enough kid-size doses — in special orange-capped vials to distinguish them from adult vaccine — for the nation’s 5- to 11-year-olds. If the vaccine is cleared, millions of doses will be promptly shipped around the country, along with kid-size needles.

More than 25,000 pediatricians and primary care providers already have signed up to get the shots into little arms.

Adblock test (Why?)

Source link

Continue Reading


Edward Rogers’ role as Blue Jays chair unchanged amid changes atop RCI –



TORONTO — Edward Rogers’ roles as chair of the Toronto Blue Jays and control person with Major League Baseball are unaffected by this week’s manoeuvrings that led to his removal as board chair of parent company Rogers Communications Inc., according to two industry sources.

Whether fallout from the power struggle atop the telecom giant, which also owns Sportsnet, might eventually reach the club is unclear. Last week, Blue Jays president and CEO Mark Shapiro said the team was “about a month away” from presenting its off-season plan during a final payroll meeting with ownership, and expressed confidence that its long-term strategic objectives would remain on track.

“Every indication I’ve received and every indication that we’ve been shown … leads me to believe that we will stay on plan and the payroll will continue to rise despite the fact that we’re still lagging behind a little bit in revenues due to (the pandemic),” Shapiro said.

Those comments came before news broke that John MacDonald, a member of the Rogers Board of Directors since 2012, had assumed the chairman role in place of Edward Rogers, who according to media reports had sought to oust company CEO Joe Natale.

Edward Rogers is now seeking to replace five board members.

At this point, the sources said the developments aren’t expected to impact a winter of opportunity for the Blue Jays, who are seeking to augment a club that missed the post-season by one game and are about to see top performers Marcus Semien, Robbie Ray and Steven Matz hit free agency.

Shapiro is close with Edward Rogers, who as chair is the top officer of the club. He is also the control person, a role each of the 30 MLB teams assigns to represent the interests of that ownership.

Adblock test (Why?)

Source link

Continue Reading